BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28417530)

  • 1. Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.
    Huang D; Lu W; Zou S; Wang H; Jiang Y; Zhang X; Li P; Songyang Z; Wang L; Wang J; Huang J; Fang L
    Cancer Sci; 2017 Jul; 108(7):1293-1302. PubMed ID: 28417530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Rho-specific guanine nucleotide dissociation inhibitor α regulation in cell migration.
    Xie F; Shao S; Aziz AUR; Zhang B; Wang H; Liu B
    Acta Histochem; 2017 Apr; 119(3):183-189. PubMed ID: 28187905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho GDP dissociation inhibitor α silencing attenuates silicosis by inhibiting RhoA/Rho kinase signalling.
    Wei Z; Xu H; Zhang Y; Yi X; Yang X; Chen Y; Mao N; Li S; Xu D; Li S; Zhang H; Li D; Zhang G; Zhang B; Jin F; Gao X; Cai W; Zhang L; Wang R; Yang F
    Exp Cell Res; 2019 Jul; 380(2):131-140. PubMed ID: 31029634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
    Zhao L; Wang H; Li J; Liu Y; Ding Y
    J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
    Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
    Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions.
    Raynaud CM; Jang SJ; Nuciforo P; Lantuejoul S; Brambilla E; Mounier N; Olaussen KA; André F; Morat L; Sabatier L; Soria JC
    Ann Oncol; 2008 Nov; 19(11):1875-81. PubMed ID: 18641004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeric repeat factor 1 protein levels correlates with telomere length in colorectal cancer.
    Valls-Bautista C; Piñol-Felis C; Reñé-Espinet JM; Buenestado-García J; Viñas-Salas J
    Rev Esp Enferm Dig; 2012; 104(10):530-6. PubMed ID: 23268632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.
    Hooshmand S; Ghaderi A; Yusoff K; Karrupiah T; Rosli R; Mojtahedi Z
    Cell Adh Migr; 2013; 7(3):297-303. PubMed ID: 23563506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDIα by Lysine Acetylation.
    Kuhlmann N; Wroblowski S; Knyphausen P; de Boor S; Brenig J; Zienert AY; Meyer-Teschendorf K; Praefcke GJK; Nolte H; Krüger M; Schacherl M; Baumann U; James LC; Chin JW; Lammers M
    J Biol Chem; 2016 Mar; 291(11):5484-5499. PubMed ID: 26719334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of GDP dissociation inhibitor 1 gene associates with the invasiveness and poor outcomes of colorectal cancer.
    Xie X; Lin H; Zhang X; Song P; He X; Zhong J; Shi J
    Bioengineered; 2021 Dec; 12(1):5595-5606. PubMed ID: 34515625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma.
    Li W; Wang H; Jin X; Zhao L
    Int J Clin Exp Pathol; 2013; 6(11):2535-41. PubMed ID: 24228117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein.
    Zhu J; Li Y; Chen C; Ma J; Sun W; Tian Z; Li J; Xu J; Liu CS; Zhang D; Huang C; Huang H
    Neoplasia; 2017 Sep; 19(9):672-683. PubMed ID: 28772241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.
    Svenson U; Öberg Å; Stenling R; Palmqvist R; Roos G
    Tumour Biol; 2016 Aug; 37(8):10877-82. PubMed ID: 26883253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells.
    Cao Z; Li X; Li J; Kang B; Chen J; Luo W; Huang C
    Mol Oncol; 2014 Mar; 8(2):285-96. PubMed ID: 24342356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma.
    Hu L; Yang GZ; Zhang Y; Feng D; Zhai YX; Gong H; Qi CY; Fu H; Ye MM; Cai QP; Gao CF
    Lab Invest; 2015 Sep; 95(9):1005-18. PubMed ID: 26121319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.